Determining the HPV vaccine schedule for a HIV-infected population in sub Saharan Africa, a commentary
Abstract Background Epidemiological studies have established human papillomavirus (HPV) infection as the central cause of invasive cervical cancer (ICC) and its precursor lesions. HIV is associated with a higher prevalence and persistence of a broader range of high-risk HPV genotypes, which in turn...
Main Authors: | Sonia Menon, Rodolfo Rossi, Mbabazi Kariisa, Steven Callens |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12985-018-1039-y |
Similar Items
-
Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination
by: Eleanor Black, et al.
Published: (2018-09-01) -
Vaccinations of International Travellers From Greece to Sub-Saharan Africa
by: Androula Pavli, et al.
Published: (2017-06-01) -
Innovative financing for HIV response in sub–Saharan Africa
by: Rifat Atun, et al.
Published: (2016-06-01) -
Stakeholder understandings of the Human Papillomavirus (HPV) vaccine in Sub-Saharan Africa: a qualitative systematic review
by: Deignan, Caroline
Published: (2020) -
Disclosure of HIV Status to Children in Sub-Saharan Africa: A Systematic Review
by: Abdul-Razak Doat, et al.
Published: (2019-08-01)